|
|
||||||||
From the Departments of Neurology (Drs. Jen, Wan, Graves, Yue, and Baloh, and H. Yu, C. Coulin, and G. Kim), Physiology (Dr. Papazian and A.F. Mock), and Surgery/Division of Head & Neck Surgery (Dr. Baloh), UCLA School of Medicine, Los Angeles, CA; and Institute of Anatomy (C. Coulin), University of Freiburg, Germany.
Address correspondence and reprint requests to Dr. J. Jen, Department of Neurology, UCLA School of Medicine, 710 Westwood Plaza, Box 951769, Los Angeles, CA 90095-1769; e-mail: jjen{at}ucla.edu
Objective: To examine the functional consequences of episodic ataxia type 2 (EA2)-causing nonsense and missense mutations in vitro and to characterize the basis of fluctuating weakness in patients with E2A.
Background: Mutations in CACNA1A encoding the Cav2.1 calcium channel subunit cause EA2 through incompletely understood mechanisms. Although the Cav2.1 subunit is important for neurotransmission at the neuromuscular junction, weakness has not been considered a feature of EA2.
Methods: The disease-causing mutations in three unrelated patients with EA2 and fluctuating weakness were identified by mutation screening and sequencing. Mutant constructs harboring mutations R1281X, F1406C, R1549X were transfected into COS7 cells and expressed for patch clamp studies. Single-fiber electromyography (SFEMG) was performed in patients to examine synaptic transmission at the neuromuscular junction.
Results: Functional studies in COS7 cells of nonsense and missense EA2 mutants demonstrated markedly decreased current densities compared with wild type. SFEMG demonstrated jitter and blocking in these patients with EA2, compared with normal subjects and three patients with SCA-6.
Conclusion: EA2-causing missense and nonsense mutations in CACNA1A produced mutant channels with diminished whole cell calcium channel activity in vitro due to loss of function. Altered biophysical properties or reduced efficiency of plasma membrane targeting of mutant channels may contribute to abnormal neuromuscular transmission, manifesting as myasthenic syndrome.
This article has been cited by other articles:
![]() |
G. Chen, L. S. Popa, X. Wang, W. Gao, J. Barnes, C. M. Hendrix, E. J. Hess, and T. J. Ebner Low-Frequency Oscillations in the Cerebellar Cortex of the Tottering Mouse J Neurophysiol, January 1, 2009; 101(1): 234 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. de Vries, H. Mamsa, A. H. Stam, J. Wan, S. L. M. Bakker, K. R. J. Vanmolkot, J. Haan, G. M. Terwindt, E. M. J. Boon, B. D. Howard, et al. Episodic Ataxia Associated With EAAT1 Mutation C186S Affecting Glutamate Reuptake Arch Neurol, January 1, 2009; 66(1): 97 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.C. Jen, T.D. Graves, E.J. Hess, M.G. Hanna, R.C. Griggs, R.W. Baloh, and the CINCH investigators Primary episodic ataxias: diagnosis, pathogenesis and treatment Brain, October 1, 2007; 130(10): 2484 - 2493. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Iida, J. Teng, T. Tada, A. Saka, M. Tamai, H. Izumi-Nakaseko, S. Adachi-Akahane, and H. Iida Essential, Completely Conserved Glycine Residue in the Domain III S2 S3 Linker of Voltage-gated Calcium Channel {alpha}1 Subunits in Yeast and Mammals J. Biol. Chem., August 31, 2007; 282(35): 25659 - 25667. [Abstract] [Full Text] [PDF] |
||||
![]() |
J C Jen, A Klein, E Boltshauser, M S Cartwright, E S Roach, H Mamsa, and R W Baloh Prolonged hemiplegic episodes in children due to mutations in ATP1A2 J. Neurol. Neurosurg. Psychiatry, May 1, 2007; 78(5): 523 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-J. Jeng, Y.-T. Chen, Y.-W. Chen, and C.-Y. Tang Dominant-negative effects of human P/Q-type Ca2+ channel mutations associated with episodic ataxia type 2 Am J Physiol Cell Physiol, April 1, 2006; 290(4): C1209 - C1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Jen, J. Wan, T. P. Palos, B. D. Howard, and R. W. Baloh Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures Neurology, August 23, 2005; 65(4): 529 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wan, R. Khanna, M. Sandusky, D. M. Papazian, J. C. Jen, and R. W. Baloh CACNA1A mutations causing episodic and progressive ataxia alter channel trafficking and kinetics Neurology, June 28, 2005; 64(12): 2090 - 2097. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. C. Weisz, R. S. Raike, L. E. Soria-Jasso, and E. J. Hess Potassium Channel Blockers Inhibit the Triggers of Attacks in the Calcium Channel Mouse Mutant tottering J. Neurosci., April 20, 2005; 25(16): 4141 - 4145. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Harno, S. Heikkinen, M. A. Kaunisto, M. Kallela, A-M. Hakkinen, M. Wessman, M. Farkkila, and N. Lundbom Decreased cerebellar total creatine in episodic ataxia type 2: A 1H MRS study Neurology, February 8, 2005; 64(3): 542 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mullner, L. A. M. Broos, A. M. J. M. van den Maagdenberg, and J. Striessnig Familial Hemiplegic Migraine Type 1 Mutations K1336E, W1684R, and V1696I Alter Cav2.1 Ca2+ Channel Gating: EVIDENCE FOR {beta}-SUBUNIT ISOFORM-SPECIFIC EFFECTS J. Biol. Chem., December 10, 2004; 279(50): 51844 - 51850. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Terwindt, E. E. Kors, A. A. Vein, M. D. Ferrari, and J. G. van Dijk Single-fiber EMG in familial hemiplegic migraine Neurology, November 23, 2004; 63(10): 1942 - 1943. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Jen, G. W. Kim, K. A. Dudding, and R. W. Baloh No Mutations in CACNA1A and ATP1A2 in Probands With Common Types of Migraine Arch Neurol, June 1, 2004; 61(6): 926 - 928. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Mantuano, L Veneziano, M Spadaro, P Giunti, S Guida, M G Leggio, L Verriello, N Wood, C Jodice, and M Frontali Clusters of non-truncating mutations of P/Q type Ca2+ channel subunit Cav2.1 causing episodic ataxia 2 J. Med. Genet., June 1, 2004; 41(6): e82 - e82. [Full Text] [PDF] |
||||
![]() |
J. S. Stahl Eye Movements of the Murine P/Q Calcium Channel Mutant Rocker, and the Impact of Aging J Neurophysiol, May 1, 2004; 91(5): 2066 - 2078. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jen, G. W. Kim, and R. W. Baloh Clinical spectrum of episodic ataxia type 2 Neurology, January 13, 2004; 62(1): 17 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.A. Maselli, J. Wan, V. Dunne, M. Graves, R.W. Baloh, R.L. Wollmann, and J. Jen Presynaptic failure of neuromuscular transmission and synaptic remodeling in EA2 Neurology, December 23, 2003; 61(12): 1743 - 1748. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |